FDA NDC Directory · JSON-LD · Markdown

RANOLAZINE

NDC 68180-355 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED, EXTENDED RELEASE

Labeler / ManufacturerLupin Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA201046
Dosage form / routeTABLET, FILM COATED, EXTENDED RELEASE · ORAL
Active ingredientsRANOLAZINE (1000 mg/1)
Marketing started20190227
Package count0

External sources

Source: openFDA. Public-domain (CC0).